Home › Forums › Main Forum › Media & News › More nausea-inducing news about Gilead’s strategy

Viewing 15 posts - 61 through 75 (of 82 total)
1 2 3 4 5 6
  • Author
    Posts
  • 30 January 2016 at 6:51 am #10794
    Avatar photoGreedfighter
    • Guardian Angel
    • ★★★★★
    @greedfighter

    Tommy, contact curehcvnow@gmail.com for help on getting meds. I would recommend that, or buyers club here.

    30 January 2016 at 7:00 am #10797
    Tommy
    • Guardian Angel
    • ★★★★★
    @tommy

    Found this site from Greg Jeffries. My insurance from my job kicks in about Feb. 14 and will be trying to find a doctor in Florida to give me a prescription for generics. My research tells me I maybe interested in the Harvoni combo (2 generics) I’m 1a with hep c for 18 years. Really appreciate the information. Sincerely.

    Genotype 1A
    ALT 473
    AST 226
    Virus Load 3,119,030
    Results as of May-2016
    5 week viral load/undetected as of 12/02/2016
    Liver Biopsy Results from Feb 2013
    Portal/Periportal chronic inflammation and mild interface hepatitis (Grade 2)
    Focal Lobular chronic inflammation (Grade 1)
    Portal/Periportal fibrosis (stage 1-2 trichrome and reticulin stains utilized)
    Negative Iron stains.

    30 January 2016 at 7:05 am #10798
    Avatar photoGreedfighter
    • Guardian Angel
    • ★★★★★
    @greedfighter

    Most doctors in USA will not write an RX for generics since there is no such thing here, and legally they might not be able to do it. http://www.gp2u.com, Dr. Freeman or Dr. Devsam in Australia/Tasmania ($70 USD) can give you an RX good for Twinvir or compounded Australian generics. Indian generics seem to be more complicated, you need an RX from an Indian doctor. Ghandi Medicos may be able to help, but importing from India may be more problematic. I’m on Twinvir and feel like it is working.

    30 January 2016 at 7:47 am #10802
    Avatar photoAriel
    • Guardian Angel
    • ★★★★★
    @ariel

    http://www.fool.com/investing/general/2016/01/29/instant-analysis-gilead-sciences-incs-longtime-ceo.aspx

    CEO steps aside yesterday, but maintains a key role and their share prices are not exactly the yuppie market they were when he took the reigns years ago, that massive profiteering time has boomed, now it is just a sick sad sack of greed…. Let’s watch Merck coming into bat with their Gen 1 and 4 tabs…at a 30% undercut, a share price of over $50 … still a compete disaster fiscally. :-1:

    30 January 2016 at 8:03 am #10803
    avatar876.jpegGaj
    • Guardian Angel
    • ★★★★★
    @gaj

    Hi Tommy,

    You may want to enquire about the Redemption trials too. Listed by NIH in U.S. http://fixhepc.com/forum/media-news/625-redemption-is-official-in-the-u-s.html

    It is organised by FixHepC and coordinated worldwide by Monkmed who I understand have a list of U.S. doctors by state who will prescribe. Sorry can’t find the post about that at the moment but mgalbrai (Mike) who started that thread is Curehcvnow@gmail.com and a very helpful guy to talk to about the U.S. situation. :)

    G3a since ’78 – Dx ’12 – F4 (2xHCC)
    24wk Tx – PEG/Riba/Dac 2013 relapsed
    24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
    16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
    SVR7 – 22/06/17 UND
    SRV12 – 27/07/17 UND
    SVR24 – 26/10/17 UND
    :cheer: :cheer: :cheer:

    30 January 2016 at 11:55 am #10808
    Avatar photoLondonGirl
    • Guardian Angel
    • ★★★★★
    @londongirl

    Thanks, LG. Very interesting! Does this mean that Gilead executives are starting to feel the heat?

    Who knows for sure, but the article and the general feeling on twitter is suggesting that..
    I mean, he’s made billions for them (and himself) so I guess he wants to be associated with success
    and now he’s off to do something else I guess that doesn’t associate him with the backlash, that does seem to be building

    GT1a Dec14 F2/8.7 VL 900000-2.5M
    Jan16 Hepcivir-L MonkMed/Redemption
    Baseline: VL 913575 Alt 76 Platelets low
    Wk2 VL1157 Alt 23
    DET Wk 8 VL 32 Alt19 ‘In the slow lane’
    June16 Fibro 5.7 F0/1 LIF 1.5
    Wk 11 VL<12 Alt 13 Det/Unq
    Extending tx 12 wks Mylan Sofo/Dac MonkMed
    Wk 14 VL <12 Det/Unq
    Wk 16 VL UNDETECTED
    Wk 22 + 4 Wks Sunprevir FixHepC
    Wk 24 UNDETECTED Alt 13
    Wk 12 post tx SVR12 Wk 26 SVR24
    Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC

    30 January 2016 at 4:34 pm #10825
    Avatar photomgalbrai
    • Guardian Angel
    • ★★★★★
    @mgalbrai

    Hi Tommy,
    Good advice here.
    I sent you a PM.
    Unless you are f-3 or f-4, you will be waiting a lot longer than for your insurance to kick in for coverage.
    Fight for you coverage if you like,
    I just got the generics and got well while I did it.
    Mike

    Curehcvnow@gmail.com
    http://forums.delphiforums.com/generichcvtx

    G 1a F-1
    Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
    11/17/15 4 wk lab ALT 17 AST 16 <15
    11/18/15 Started Harvoni
    12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
    1/14/16 Fin. Tx
    7/07/16 UND SVR 24

    3 February 2016 at 1:44 am #11052
    Avatar photoVororo
    • Guardian Angel
    • ★★★★★
    @vororo

    Gilead has just posted Q4 sales for 2015.

    http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-earnings

    * Total sales in Q4 2015: $8.4 billion (up from $7.2 billion in Q4 2014), of which antivirals account for $7.9 billion.

    * Total sales for 2015: $32.2 billion (up from $24.5 billion in 2014), primarily from Sovaldi at $21.2 billion, compared to $18.1 billion in 2014.

    … Draw your own conclusions?

    Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
    Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
    Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
    Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3).

    3 February 2016 at 2:16 am #11056
    Avatar photoTina-Hill-facebook
    • Guardian Angel
    • ★★★★★
    @tina-hill-facebook

    From the San Francisco Chronicle.

    http://www.sfchronicle.com/opinion/openforum/article/Pricey-hepatitis-C-drugs-threaten-health-care-6751291.php

    Below is another article from Radio NZ detailing what the ramifications are in relation to the TPPA and access to medicines if this trade agreement is ratified. Although Gilead is not mentioned you can bet they have had significant input.

    http://www.radionz.co.nz/news/political/295501/anti-tpp-group-warns-of-us-drug-plan

    SVR 24

    3 February 2016 at 3:59 am #11066
    Avatar photoTina-Hill-facebook
    • Guardian Angel
    • ★★★★★
    @tina-hill-facebook

    Hey Mike

    Congrats on the moderator status – just saw that now. Looks like you are getting a good following from HCV people in the states. You suit your nick name of The Pied Piper. :+1:

    SVR 24

    3 February 2016 at 4:07 am #11067
    Avatar photomgalbrai
    • Guardian Angel
    • ★★★★★
    @mgalbrai

    Thank you.
    I still view myself as an “enlisted” man. I suppose “warrant officer” will be tolerable. I will just keep piping and try not to poke the wrong buttons.
    M

    Curehcvnow@gmail.com
    http://forums.delphiforums.com/generichcvtx

    G 1a F-1
    Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
    11/17/15 4 wk lab ALT 17 AST 16 <15
    11/18/15 Started Harvoni
    12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
    1/14/16 Fin. Tx
    7/07/16 UND SVR 24

    3 February 2016 at 4:30 am #11070
    avatar876.jpegGaj
    • Guardian Angel
    • ★★★★★
    @gaj
    mgalbrai wrote:

    ……..try not to poke the wrong buttons.
    M

    image.jpeg

    Oh wait…..that’s over at that other site isn’t it! B)

    G3a since ’78 – Dx ’12 – F4 (2xHCC)
    24wk Tx – PEG/Riba/Dac 2013 relapsed
    24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
    16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
    SVR7 – 22/06/17 UND
    SRV12 – 27/07/17 UND
    SVR24 – 26/10/17 UND
    :cheer: :cheer: :cheer:

    8 February 2016 at 2:31 pm #11497
    Avatar photoAriel
    • Guardian Angel
    • ★★★★★
    @ariel

    Hahaahaaaha Mike! :evil:

    8 February 2016 at 3:12 pm #11502
    Avatar photoLondonGirl
    • Guardian Angel
    • ★★★★★
    @londongirl

    Gilead are rather clever at forward thinking. They offer financial support to organisations in need. ie Charities and Public Health Authorities and of course, seeing as they need Dr research too ….some Drs.

    GT1a Dec14 F2/8.7 VL 900000-2.5M
    Jan16 Hepcivir-L MonkMed/Redemption
    Baseline: VL 913575 Alt 76 Platelets low
    Wk2 VL1157 Alt 23
    DET Wk 8 VL 32 Alt19 ‘In the slow lane’
    June16 Fibro 5.7 F0/1 LIF 1.5
    Wk 11 VL<12 Alt 13 Det/Unq
    Extending tx 12 wks Mylan Sofo/Dac MonkMed
    Wk 14 VL <12 Det/Unq
    Wk 16 VL UNDETECTED
    Wk 22 + 4 Wks Sunprevir FixHepC
    Wk 24 UNDETECTED Alt 13
    Wk 12 post tx SVR12 Wk 26 SVR24
    Thank-you Tim, Dr Debasis @ MonkMed & Dr Freeman @ Fix HepC

    11 February 2016 at 1:45 am #11705
    Avatar photosabrecat
    • Guardian Angel
    • ★★★★★
    @sabrecat

    Found this post on a site when researching getting battery storage for my solar panels:

    USD3000 in USA and $15000 here [Australia]. Someone is kidding – or making a killing. I suspect reverse calculated what the market could bear off our high electricity prices rather than actual costs and margins. If greed doesnt get in the way this will be the future at some point – but as an engineer I will wait a few product cycles to get this all sorted , safe and reliable – and properly priced with competition.

    Suc is life said a more honest man…

    J.

  • Author
    Posts
Viewing 15 posts - 61 through 75 (of 82 total)
1 2 3 4 5 6
  • You must be logged in to reply to this topic.